Atea Pharmaceuticals (AVIR) Receivables (2021 - 2022)
Atea Pharmaceuticals (AVIR) recorded quarterly Receivables of $4.5 million in Q3 2022, down 90.97% quarter-over-quarter from $50.0 million in Q2 2021.
Atea Pharmaceuticals (AVIR) Receivables (2021 - 2022) Analysis & Trends
Atea Pharmaceuticals' Receivables history runs 2 years deep, the most recent figure standing at $4.5 million for Q3 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | 13.10 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | 2.00 Bn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | - |
| 10 | Atea Pharmaceuticals | 347.28 Mn | 347.28 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2022 | 4.51 Mn |
| Jun 30, 2021 | 50.00 Mn |